Blueprint Medicines amends IPO

Blueprint Medicines Corp., Cambridge, Mass. Business: Cancer Date announced: 2015-04-21 Type: IPO To be raised: Up to $122.2 million Shares: 7.2 million Price: $15-$17 Underwriters: Goldman Sachs; Cow...